Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.1 (
ACS
)
78,556
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mn
4+
-activated oxide phosphors La(MgTi)
1/2
O
3
(
LMT
) with far-red emitting were prepared via a sol-gel route. The structures of samples were determined by X-ray diffraction (XRD) and Reitveld refinement. The occupied sites of Mn
4+
(d
3
electronic configuration) in host La(MgTi)
1/2
O
3
were confirmed by ab initio calculations in which the system has the lower formation energy, stable lattice structure, and strong bonding state as Mn
4+
enters into Ti site. The luminescent properties of Mn
4+
-doped samples were investigated; the samples emit far-red light centered at 708 nm with ultraviolet light (345 nm) or blue light (487 nm) excitation. According to the photoluminescence (PL) and excitation (PLE) spectra, the crystal field strength of the Mn
4+
-occupied environment was estimated. The thermal stability of phosphor was also evaluated through temperature-dependent PL intensity in a heating and cooling cycle process. The emission band is well-matched with the absorption band of phytochrome P
FR
under the excitation of light in near-ultraviolet to blue, which suggests that the
LMT
: Mn
4+
phosphor has great potential applications in light-emitting diodes (LEDs) for modulating plant growth.
ACS
Appl Mater Interfaces 2017 Feb 22
PMID:Ab Initio Site Occupancy and Far-Red Emission of Mn
4+
in Cubic-Phase La(MgTi)
1/2
O
3
for Plant Cultivation. 2811 96
